Publicacións nas que colabora con Javier Fernández Castroagudín (19)

2015

  1. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante

    Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637

2014

  1. "very early" intrahepatic cholangiocarcinoma in cirrhotic patients: Should liver transplantation be reconsidered in these patients?

    American Journal of Transplantation, Vol. 14, Núm. 3, pp. 660-667

  2. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: A spanish matched cohort multicenter study

    Annals of Surgery, Vol. 259, Núm. 5, pp. 944-952

2013

  1. A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: A randomised controlled study

    Anaesthesia and Intensive Care, Vol. 41, Núm. 6, pp. 719-727

2011

  1. Calcineurin inhibitors in liver transplantation: To be or not to be

    Transplantation Proceedings, Vol. 43, Núm. 6, pp. 2220-2223

2009

  1. Chronic nephropathy in non-kidney transplantation: [prevention, early diagnosis and management

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 29, Núm. 4 Suppl, pp. 1-16

  2. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

    Liver Transplantation, Vol. 15, Núm. 12, pp. 1792-1797

  3. Safety of an Immunosuppressant Protocol Based on Sirolimus in Liver Transplant Recipients With Malignancies or High Risk of Tumor Recurrence

    Transplantation Proceedings, Vol. 41, Núm. 3, pp. 1003-1004

2008

  1. Orthotopic Liver Transplantation for Hepatocellular Carcinoma: A Thirteen-Year Single-Center Experience

    Transplantation Proceedings, Vol. 40, Núm. 9, pp. 2975-2977

2005

  1. Doppler ultrasonography for the assessment of tumor necrosis after percutaneous ethanol injection prior to liver transplantation as adjuvant therapy of hepatocellular carcinoma

    Transplantation Proceedings

  2. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation

    Transplantation Proceedings

  3. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients

    Transplantation Proceedings

  4. Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates

    Transplantation Proceedings

2003

  1. Utility of ambulatory blood pressure monitoring for diagnosis of hypertension in liver allograft recipients

    Transplantation Proceedings

2002

  1. Alternative immunosuppression for acute renal failure in liver transplantation: Role of ultra-low dose tacrolimus and basiliximab

    Transplantation Proceedings

  2. Bilateral adrenal metastases from hepatocellular carcinoma after liver transplantation

    Hepato-Gastroenterology, Vol. 49, Núm. 43, pp. 249-251

  3. Cardiovascular risk factors in liver allograft recipients: Relationship with immunosuppressive therapy

    Transplantation Proceedings

  4. Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus

    Transplantation Proceedings

2000

  1. Intensive care during prolonged anhepatic state after total hepatectomy and porto-caval shunt (two-stage procedure) in surgical complications of liver transplantation

    Hepato-Gastroenterology, Vol. 47, Núm. 35, pp. 1343-1346